EUVIMEDEUVIMED entdecken
Crossref

Use of otilonium bromide in the treatment of abdominal pain

I. G. Pakhomova

Meditsinskiy sovet = Medical Council · 01.07.2026 · (8) · 164-169

DOI: 10.21518/ms2026-185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 01.07.2026. Verfasst von I. G. Pakhomova. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal pain is a fairly common clinical problem encountered by clinicians. The causes of abdominal pain can be varied (both functional and organic). Abdominal pain is a fairly common clinical problem and is a serious issue in internal medicine and gastroenterology. Abdominal pain is the primary symptom of irritable bowel syndrome (IBS) and is primarily associated with intestinal smooth muscle spasm. However, abdominal pain caused by spasm can also occur with other conditions, such as biliary system disorders, specifically functional disorders of the gallbladder and sphincter of Oddi, and painful colonic spasms associated with IBS-like symptoms associated with underlying organic bowel pathology in remission (diverticular disease, inflammatory bowel disease in remission, and others). Antispasmodics are the drugs of choice for abdominal pain with a spastic component. The domestic pharmaceutical market offers various classes of antispasmodics, including selective calcium channel blockers. One such selective calcium channel blocker is otilonium bromide, which is widely used worldwide. It is effective, well-tolerated, and superior to placebo in reducing symptoms and preventing pain recurrence in patients with both IBS and other intestinal spasticity. The drug’s selective action and low intestinal absorption result in minimal side effects and the potential for otilonium bromide use in patients with comorbidities, including long-term use. This article presents two clinical cases of abdominal pain: a female patient with a long history of IBS and a patient with uncomplicated diverticular disease with IBS-like manifestations. These cases highlight the potential use of otilonium bromide.

Zitieren

APA

Pakhomova, I. G. (2026). Use of otilonium bromide in the treatment of abdominal pain. Meditsinskiy sovet = Medical Council, 164-169. https://doi.org/10.21518/ms2026-185

Vancouver

Pakhomova IG. Use of otilonium bromide in the treatment of abdominal pain. Meditsinskiy sovet = Medical Council. 2026:164-169. doi:10.21518/ms2026-185

BibTeX
@article{Pakhomova2026,
  author = {Pakhomova, I. G.},
  title = {Use of otilonium bromide in the treatment of abdominal pain},
  journal = {Meditsinskiy sovet = Medical Council},
  year = {2026},
  number = {8},
  pages = {164--169},
  doi = {10.21518/ms2026-185}
}
Kostenlos starten →